F Grumbach

422 total citations
36 papers, 304 citations indexed

About

F Grumbach is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, F Grumbach has authored 36 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 11 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in F Grumbach's work include Tuberculosis Research and Epidemiology (23 papers), Mycobacterium research and diagnosis (10 papers) and Diagnosis and treatment of tuberculosis (5 papers). F Grumbach is often cited by papers focused on Tuberculosis Research and Epidemiology (23 papers), Mycobacterium research and diagnosis (10 papers) and Diagnosis and treatment of tuberculosis (5 papers). F Grumbach collaborates with scholars based in France. F Grumbach's co-authors include G Canetti, N Rist, J Grosset, G Biozzi, Baruj Benacerraf, Halpern Bn, G. Girard and J. Grosset and has published in prestigious journals such as PubMed, Tubercle and Ann. Inst. Pasteur.

In The Last Decade

F Grumbach

32 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Grumbach France 10 222 172 87 49 43 36 304
Mitchison Da United Kingdom 11 246 1.1× 198 1.2× 90 1.0× 65 1.3× 6 0.1× 20 317
Chantal Truffot France 7 336 1.5× 406 2.4× 72 0.8× 60 1.2× 11 0.3× 11 467
V. Bühler United States 6 121 0.5× 207 1.2× 75 0.9× 18 0.4× 5 0.1× 8 255
T Uzawa Japan 6 54 0.2× 329 1.9× 26 0.3× 41 0.8× 36 0.8× 9 456
Edward Lyon United States 5 194 0.9× 133 0.8× 61 0.7× 88 1.8× 17 0.4× 5 289
Pearl Fisher United States 7 148 0.7× 373 2.2× 16 0.2× 43 0.9× 179 4.2× 7 552
K. Bartmann Germany 9 77 0.3× 66 0.4× 17 0.2× 31 0.6× 37 0.9× 67 242
Rosemary V. Swanson United States 7 205 0.9× 180 1.0× 40 0.5× 82 1.7× 31 0.7× 15 345
Grace Muzanye United States 7 397 1.8× 329 1.9× 136 1.6× 72 1.5× 18 0.4× 7 465
Lisa C. Goldfeder United States 8 312 1.4× 234 1.4× 148 1.7× 48 1.0× 26 0.6× 11 381

Countries citing papers authored by F Grumbach

Since Specialization
Citations

This map shows the geographic impact of F Grumbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Grumbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Grumbach more than expected).

Fields of papers citing papers by F Grumbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Grumbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Grumbach. The network helps show where F Grumbach may publish in the future.

Co-authorship network of co-authors of F Grumbach

This figure shows the co-authorship network connecting the top 25 collaborators of F Grumbach. A scholar is included among the top collaborators of F Grumbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Grumbach. F Grumbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grumbach, F, et al.. (1970). [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].. PubMed. 34(2). 312–9. 4 indexed citations
2.
Grumbach, F. (1969). [Rifomycin in continuous and intermittent combined treatment of experimental tuberculosis in mice].. PubMed. 60(3). 390–6. 1 indexed citations
3.
Grumbach, F, et al.. (1969). Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results. Tubercle. 50(3). 280–293. 64 indexed citations
4.
Canetti, G & F Grumbach. (1968). Experiments on long-term intermittent chemotherapy in advanced tuberculosis in mice. Tubercle. 49. 70–74. 7 indexed citations
5.
Grumbach, F. (1968). [Intermittent long-term cheomotherapy in experimental tuberculosis of the mouse].. PubMed. 41. 303–8. 1 indexed citations
6.
Grumbach, F, et al.. (1968). [Tuberculosis bacilli of the African type: preliminary note].. PubMed. 32(2). 179–84. 44 indexed citations
7.
Grumbach, F, et al.. (1967). Late results of long-term, intermittent chemotherapy of advanced, murine tuberculosis: Limits of the murine model. Tubercle. 48(1). 11–26. 19 indexed citations
8.
Grumbach, F. (1966). Antituberculous Activity in Mice of Ethambutol (Dextro-2,2'-Ethylenediimino) di-iButanol Associated with Isoniazid and Ethionamide.. Ann. Inst. Pasteur. 110(1). 69–85. 1 indexed citations
9.
Grumbach, F. (1966). Study of virulence in guinea pigs of mycobacterium tuberculosis strains from the Republic of Madagascar. Comparison of their virulence in guinea pigs and mice.. PubMed. 38(1). 49–51. 1 indexed citations
10.
Grumbach, F. (1965). [Chemotherapeutic studies on advanced tuberculosis in mice].. PubMed. 21. 31–96. 4 indexed citations
11.
Grumbach, F. (1965). Experimental basis for the chemotherapy of tuberculosis.. PubMed. 5. 1058–64. 3 indexed citations
12.
Rist, N, et al.. (1963). [The S-oxide of gamma-ethylthioisonicotinamide].. PubMed. 257. 307–8. 2 indexed citations
13.
14.
Grumbach, F. (1960). [Experimental antituberculous activity of 2 derivatives of pigmented phenazine (B 663 and B 720) alone and combined with other antitubercular agents (Isoniazid and ethoniamide)].. PubMed. 99. 567–85. 1 indexed citations
15.
Canetti, G, F Grumbach, & J Grosset. (1960). Studies of bacillary populations in experimental tuberculosis of mice treated by isoniazid.. PubMed. 82. 295–313. 9 indexed citations
16.
Grumbach, F. (1958). Experimental Antituberculous Activity of Pyrazinamide (PZA).. Ann. Inst. Pasteur. 94(6). 694–708. 1 indexed citations
17.
Girard, G. & F Grumbach. (1958). [Tuberculous infection of the mouse involves its resistance to experimental plague infection].. PubMed. 152(2). 280–2. 4 indexed citations
18.
Rist, N, et al.. (1957). [Relationship between the chemical constitution and tuberculostatic activity of substituted isonicotinic thioamides].. PubMed. 39(9-10). 1195–200.
19.
Rist, N, et al.. (1955). [Pathogenic power of isoniazid resistant Mycobacterium tuberculosis].. PubMed. 19(6). 659–79. 1 indexed citations
20.
Rist, N, et al.. (1951). [A new derivative of PAS, phenyl paraaminosalicylate or FR7; tuberculostatic activity in vitro and in the mouse].. PubMed. 81(4). 407–23. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitchison Da Breakdown of academic impact, for papers by Chantal Truffot Breakdown of academic impact, for papers by V. Bühler Breakdown of academic impact, for papers by T Uzawa Breakdown of academic impact, for papers by Edward Lyon Breakdown of academic impact, for papers by Pearl Fisher Breakdown of academic impact, for papers by K. Bartmann Breakdown of academic impact, for papers by Rosemary V. Swanson Breakdown of academic impact, for papers by Grace Muzanye Breakdown of academic impact, for papers by Lisa C. Goldfeder
Rankless by CCL
2026